New advances in targeted therapy: How does Abemaci..

created a new article

1 d

New advances in targeted therapy: How does Abemaciclib slow the progression of breast cancer? | #cancer

New advances in targeted therapy: How does Abemaciclib slow the progression of breast cancer?

New advances in targeted therapy: How does Abemaciclib slow the progression of breast cancer?

Abemaciclib is a CDK4/6 inhibitor anti-tumor drug, mainly used for patients with hormone receptor-positive (HR+) and HER2-negative (HER2-) advanced or metastatic breast cancer. It is often used in combination with endocrine therapy to slow disease progression.

Like

Comment

Share